MOLN
Molecular Partners AG ADR
NASDAQ: MOLN · HEALTHCARE · BIOTECHNOLOGY
$4.23
-4.94% today
Updated 2026-04-30
Market cap
$162.74M
P/E ratio
—
P/S ratio
158.42x
EPS (TTM)
$-2.10
Dividend yield
—
52W range
$3 – $5
Volume
0.0M
Molecular Partners AG ADR (MOLN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $32.42M | $26.63M | $29.12M | $23.04M | $20.02M | $10.36M | $20.38M | $9.34M | $9.33M | $189.56M | $7.04M | $4.97M | $0.00 |
| Revenue growth (YoY) | — | -17.9% | +9.4% | -20.9% | -13.1% | -48.3% | +96.8% | -54.2% | -0.1% | +1931.7% | -96.3% | -29.4% | -100.0% |
| Cost of revenue | $1.22M | $170750.00 | $1.17M | $14.57M | $17.82M | $15.60M | $43.50M | $56.08M | $55.72M | $50.75M | $47.84M | $47.50M | — |
| Gross profit | $31.20M | $26.45M | $27.95M | $8.47M | $2.19M | $-5.25M | $-23.11M | $-46.73M | $-46.39M | $138.81M | $-40.81M | $-42.53M | — |
| Gross margin | 96.2% | 99.4% | 96.0% | 36.8% | 11.0% | -50.7% | -113.4% | -500.1% | -497.2% | 73.2% | -579.8% | -855.8% | — |
| R&D | $20.82M | $18.79M | $23.92M | $35.19M | $37.45M | $38.20M | $43.50M | $56.08M | $55.72M | $50.75M | $48.78M | $48.60M | $40.19M |
| SG&A | $3.59M | $4.90M | $6.22M | $7.24M | $8.28M | $9.46M | $13.16M | $11.03M | $16.91M | $21.82M | $19.00M | $17.16M | $14.87M |
| Operating income | $7.12M | $1.84M | $-2.22M | $-19.49M | $-25.84M | $-37.41M | $-36.66M | $-58.33M | $-63.42M | $116.61M | $-61.11M | $-61.22M | $-58.12M |
| Operating margin | 22.0% | 6.9% | -7.6% | -84.6% | -129.1% | -361.3% | -179.9% | -624.2% | -679.7% | 61.5% | -868.3% | -1231.7% | — |
| EBITDA | $7.93M | $-1.47M | $760000.00 | $-17.52M | $-24.70M | $-36.11M | $-33.70M | $-59.58M | $-60.66M | $119.00M | $-59.52M | $-51.65M | $-59.49M |
| EBITDA margin | 24.5% | -5.5% | 2.6% | -76.1% | -123.4% | -348.7% | -165.3% | -637.7% | -650.2% | 62.8% | -845.6% | -1039.2% | — |
| EBIT | $7.14M | $-2.28M | $-149386.00 | $-18.61M | $-25.84M | $-37.04M | $-36.17M | $-62.47M | $-63.23M | $116.61M | $-61.94M | $-54.02M | $-61.63M |
| Interest expense | $8293.00 | $853.00 | $154000.00 | $89000.00 | $197000.00 | $102000.00 | $100625.00 | $323881.00 | $608137.00 | $648123.00 | $49000.00 | $25000.00 | $18000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $7.14M | $-2.28M | $-148823.00 | $-18.61M | $-25.43M | $-37.04M | $-36.29M | $-62.76M | $-63.78M | $117.85M | $-61.98M | $-54.04M | $-61.65M |
| Net income growth (YoY) | — | -132.0% | +93.5% | -12406.1% | -36.6% | -45.6% | +2.0% | -73.0% | -1.6% | +284.8% | -152.6% | +12.8% | -14.1% |
| Profit margin | 22.0% | -8.6% | -0.5% | -80.8% | -127.0% | -357.7% | -178.0% | -671.7% | -683.7% | 62.2% | -880.7% | -1087.4% | — |